Quarterly ResultAug 11, 2026, 08:11 AM
Neuronetics Q2 Adj. EBITDA $0.3M; Net Loss Narrows to $3.4M
AI Summary
Neuronetics, Inc. reported strong second quarter 2026 financial results, achieving positive Adjusted EBITDA of $0.3 million, a significant improvement from a $5.6 million loss in the prior year. Total revenue grew 9.1% to $41.6 million, driven by a 16.8% increase in Greenbrook revenue. The company also narrowed its net loss to $3.4 million and improved its gross margin to 51.1%, while reducing operating expenses by 12%. Neuronetics updated its full-year 2026 guidance, raising gross margin expectations and lowering operating expense projections, alongside an improved outlook for cash flow from operations and investing. The company also strengthened its leadership team with key appointments.
Key Highlights
- Total revenue increased 9.1% to $41.6 million in Q2 2026.
- Adjusted EBITDA turned positive at $0.3 million, up from a $5.6 million loss in Q2 2025.
- Net loss significantly narrowed to $3.4 million from $10.1 million in Q2 2025.
- Gross margin improved to 51.1% in Q2 2026 from 46.6% in Q2 2025.
- Operating expenses decreased 12% to $22.7 million in Q2 2026.
- FY 2026 gross margin guidance raised to 48%-50%; operating expenses lowered to $91M-$96M (ex-SBC).
- FY 2026 cash flow from operations and investing guidance improved to -$10.5M to -$14.5M.
- Nir Naor appointed CFO; Cory Anderson promoted to EVP/GM Greenbrook; Rob Greene appointed SVP, Sales.
Price Impact
More from STIM